Trademarkia Logo

Canada

C$
Trademark Search in Canada
LYFAQUIN

View On IC.GC.CA

LYFAQUIN
REGISTERED

on 24 Aug 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

PHARMAZZ INC.

50 West 75th Street, Suite 105Willowbrook IL 60527

US

Serial Number

2075759 filed on 29th Sept 2020

Registration Number

TMA1139852 registered on 24th Aug 2022

Registration expiry Date

29th Sept 2030

LYFAQUIN

Trademark usage description

pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's dise Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.

Classification kind code

11

Mark Details

Serial Number

2075759

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 222
on 30th May 2022		Opposition Start Date Notice Sent
Submitted for opposition 27
on 3rd May 2022		Approval Notice Sent
Submitted for opposition 26
on 3rd May 2022		Approved
Submitted for opposition 22
on 27th Apr 2022		Search Recorded
Submitted for opposition 256
on 8th Nov 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 7th Jan 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 6th Jan 2021		Formalized
Submitted for opposition 1
on 6th Jan 2021		Created
Submitted for opposition 228
on 29th Sept 2020		International Registration
Submitted for opposition 30
on 29th Sept 2020		Filed

This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy and Terms & Conditions.
Manage cookies

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.